Hexanucleotide repeat expansion in C9orf72 represents the most common genetic cause of familial and sporadic behavioural variant frontotemporal dementia. Previous studies show that some C9orf72 carriers with behavioural variant frontotemporal dementia exhibit distinctive atrophy patterns whereas others show mild or undetectable atrophy despite severe behavioural impairment. To explore this observation, we examined intrinsic connectivity network integrity in patients with or without the C9orf72 expansion. We studied 28 patients with behavioural variant frontotemporal dementia, including 14 C9orf72 mutation carriers (age 58.3 AE 7.7 years, four females) and 14 non-carriers (age 60.8 AE 6.9 years, four females), and 14 age-and sexmatched healthy controls. Both patient groups included five patients with comorbid motor neuron disease. Neuropsychological data, structural brain magnetic resonance imaging, and task-free functional magnetic resonance imaging were obtained. Voxelbased morphometry delineated atrophy patterns, and seed-based intrinsic connectivity analyses enabled group comparisons of the salience, sensorimotor, and default mode networks. Single-patient analyses were used to explore network imaging as a potential biomarker. Despite contrasting atrophy patterns in C9orf72 carriers versus non-carriers, patient groups showed topographically similar connectivity reductions in the salience and sensorimotor networks. Patients without C9orf72 expansions exhibited increases in default mode network connectivity compared to controls and mutation carriers. Across all patients, behavioural symptom severity correlated with diminished salience network connectivity and heightened default mode network connectivity. In C9orf72 carriers, salience network connectivity reduction correlated with atrophy in the left medial pulvinar thalamic nucleus, and this region further showed diminished connectivity with key salience network hubs. Single-patient analyses revealed salience network disruption and default mode network connectivity enhancement in C9orf72 carriers with earlystage or slowly progressive symptoms. The findings suggest that patients with behavioural variant frontotemporal dementia with or without the C9orf72 expansion show convergent large-scale network breakdowns despite distinctive atrophy patterns. Medial pulvinar degeneration may contribute to the behavioural variant frontotemporal dementia syndrome in C9orf72 carriers by disrupting salience network connectivity. Task-free functional magnetic resonance imaging shows promise in detecting earlystage disease in C9orf72 carriers and may provide a unifying biomarker across diverse anatomical variants.
Introduction
Hexanucleotide expansion in C9orf72 represents the most common genetic mutation causing familial and sporadic behavioural variant frontotemporal dementia (bvFTD) and amyotrophic lateral sclerosis (ALS) (DeJesus-Hernandez et al., 2011; Renton et al., 2011) . Previous series reveal heterogeneous clinical presentations in C9orf72 carriers, whose predominant phenotypes include bvFTD, bvFTD with motor neuron disease (bvFTD-MND), and ALS (DeJesus-Hernandez et al., 2011; Renton et al., 2011) . In some bvFTD series, C9orf72 carriers manifested greater psychosis and episodic memory impairment than non-carriers Simó n-Sá nchez et al., 2012; Snowden et al., 2012) , but the core bvFTD clinical features emerge regardless of C9orf72 status.
Group-level neuroimaging analyses demonstrate that patients with C9orf72 + bvFTD show symmetric atrophy most prominent in the anterior insula, anterior cingulate, and frontotemporal cortex, in keeping with the sporadic bvFTD-associated pattern Mahoney et al., 2012; Sha et al., 2012; Whitwell et al., 2012; Irwin et al., 2013) . Some studies have reported that C9orf72 carriers also show parietal (Sha et al., 2012; Whitwell et al., 2012; Irwin et al., 2013) and occipital (Sha et al., 2012; Whitwell et al., 2012) atrophy not typical of sporadic bvFTD, creating a more distributed atrophy pattern. Patient-level findings suggest even greater heterogeneity; patients with mild, slowly progressive, or even advanced dementia may show little or no atrophy Khan et al., 2012) . Some group-level studies have described greater thalamic (Mahoney et al., 2012; Sha et al., 2012; Irwin et al., 2013) and cerebellar (Mahoney et al., 2012; Whitwell et al., 2012; Irwin et al., 2013) atrophy in C9orf72 + bvFTD, whereas others have emphasized mild atrophy in frontal, temporal, insular and parietal cortex with no significant thalamic atrophy (Whitwell et al., 2012) .
We reasoned that intrinsic connectivity network (ICN) analysis could help clarify systems-level dysfunction in C9orf72 + bvFTD, including patients with atypical, mild, or absent structural brain atrophy. ICNs are temporally synchronous, low frequency (50.08 Hz) fluctuations in blood oxygen level-dependent signal and correspond with regional ensembles recruited in taskactivation functional MRI studies (Smith et al., 2009) . Neurodegenerative disease syndromes have been linked to atrophy within distinct ICNs (Seeley et al., 2009) , and ICN measures have proven sensitive to disease even in regions lacking structural atrophy (Gardner et al., 2013; Dopper et al., 2014) . Previous studies have identified bvFTD-associated atrophy (Seeley et al., 2009) and intrinsic connectivity disruptions Whitwell et al., 2011; Farb et al., 2013; Filippi et al., 2013) in the salience network, an ICN whose major nodes include the anterior insula, anterior cingulate cortex, amygdala, ventral striatum, and medial thalamus, regions proposed to represent the emotional significance of internal and external stimuli and coordinate contextualized viscero-autonomic, cognitive, and behavioural responses (Seeley et al., 2007) . While the anterior 'social brain' degenerates in bvFTD, posterior cortical functions may flourish, corresponding with focally enhanced intrinsic connectivity within a hippocampal-cingulo-temporal-parietal network referred to as the default mode network (DMN) Borroni et al., 2012; Whitwell et al., 2011; Farb et al., 2013) . In ALS, studies of a sensorimotor network (SMN) composed of primary motor and sensory cortices and supplementary motor areas (Biswal et al., 1995) show connectivity decreases in dorsomedial prefrontal cortex (Mohammadi et al., 2009) and primary motor cortex (Tedeschi et al., 2012) , and increases in Rolandic, premotor, and dorsolateral prefrontal cortices (Douaud et al., 2011) , suggesting unbalanced or compensatory network connectivity.
Here, we compared intrinsic connectivity in 14 patients with C9orf72 + bvFTD (five with comorbid MND) with 14 patients with sporadic bvFTD (five with MND) and healthy control participants. We hypothesized that (i) patients with bvFTD with or without C9orf72 expansions would demonstrate convergent salience network connectivity reductions, reflecting the shared bvFTD syndrome; (ii) bidirectional SMN connectivity changes consistent with the ALS literature would be seen in both patient groups, each including five patients with MND; and (iii) C9orf72 + bvFTD would exhibit greater DMN connectivity reduction compared with sporadic bvFTD, in line with previous studies reporting greater parietal atrophy in C9orf72 + bvFTD. We also explored connectivity-behaviour correlations and single-patient ICN analyses in early-stage and slowly progressive disease.
Materials and methods

Participants
Fourteen right-handed C9orf72 carriers (negative for MAPT and GRN mutations) in the University of California, San Francisco Memory and Aging Centre database met bvFTD criteria (Neary et al., 1998) and had undergone task-free functional MRI scanning. Patients were diagnosed prospectively with consensus criteria in use at the time of evaluation (Neary et al., 1998) and reassessed using the Frontotemporal Dementia Consortium (FTDC) criteria (Rascovsky et al., 2011) . Twelve of 14 met probable and two met possible bvFTD FTDC criteria due to a lack of brain imaging abnormalities. Five of 14 patients with C9orf72 + bvFTD had comorbid MND. Patients were designated bvFTD-MND if they met Neary bvFTD criteria and (i) probable ALS criteria (Brooks et al., 2000) ; or (ii) had evidence of ALS-spectrum disease (primary lateral sclerosis or lower motor neuron signs) involving bulbar musculature or more than one spinal level. A bvFTD comparison group, negative for MAPT, GRN, and C9orf72 mutations (Supplementary material) was matched to the C9orf72 + bvFTD patients for age, sex, education, handedness and scanner. All C9orf72À bvFTD patients met Neary and probable bvFTD FTDC criteria. In each bvFTD group, four patients had bvFTD-ALS and one had bvFTD-MND (with predominant upper motor neuron involvement). The proportion taking CNS-acting medications did not differ among patients with or without C9orf72 ( 2 = 2.8, P = 0.09; Supplementary material).
Neurological and neuropsychological assessments occurred within 180 days of MRI scanning. The Frontotemporal Lobar Degenerationmodified Clinical Dementia Rating (FTLD-CDR) scale evaluated functional status (Morris, 1993; Knopman et al., 2008) . The Neuropsychiatric Inventory (NPI) measured behavioural symptoms (Cummings et al., 1994) ; we created an NPI composite score, the sum of the apathy, disinhibition, eating, euphoria, and aberrant motor behaviour subscales, because four of these subscales (apathy, disinhibition, eating, and aberrant motor behavior) parallel the FTDC core bvFTD clinical criteria, and all five (including euphoria) are significantly increased in patients with FTD compared with Alzheimer's disease (Liu et al., 2004) .
Healthy controls for voxel-based morphometry (HC1, n = 42, Supplementary material) and task-free functional MRI (HC2, n = 14) were matched to patient groups for age, sex, education, handedness and scanner. All HC2 had a FTLD-CDR = 0 and those tested (n = 10) had a Mini-Mental State Examination score (Folstein et al., 1983) 427/30; both HC1 and HC2 had no significant history of neurological disease, and a brain MRI free of significant white matter changes or other lesions.
We performed single-patient voxel-based morphometry and taskfree functional MRI analyses on four C9orf72 carriers. Two had mild behavioural symptoms not meeting Neary or FTDC bvFTD criteria, and two previously described carriers included in the group analyses had slowly progressive bvFTD (Khan et al., 2012) . For single patient analyses, 30 healthy control participants were matched to each patient for age, sex, education, handedness, and scanner (Supplementary material). Patient anonymity was protected by altering minor clinical details.
The University of California, San Francisco Committee on Human Research approved the study. Participants or their surrogates provided informed consent before participation.
Image acquisition
Ten participants per patient group underwent 3 T MRI scanning; four per patient group underwent 4 T MRI scanning. Healthy controls for voxel-based morphometry and ICN analyses were scanned at an equal proportion of 3 T and 4 T scans as the patient groups (Supplementary material).
Structural imaging
Volumetric magnetization prepared rapid gradient echo sequences obtained T 1 -weighted images with parameters as follows: 3 T: repetition time: 2300 ms; echo time: 2.98 ms; flip angle 9 ; 160 sagittal slices; To minimize confounding effects of using two scanners, we balanced patient and control groups for scanner site and entered site as a nuisance covariate in all regression analyses, following previous approaches Sha et al., 2012) .
Image processing and analysis
Structural imaging
Voxel-based morphometry was performed using the SPM8 VBM8 toolbox (http://www.fil.ion.ucl.ac.uk/spm/). T 1 -weighted images were preprocessed with VBM8 default estimation settings, normalized using standard spatial normalization with a light clean up, modulated, corrected for non-linear warping, then segmented into grey and white matter images. Grey matter images were smoothed using an 8 mm full-width at half-maximum isotropic Gaussian kernel. As our primary question concerned how patients with bvFTD with and without the C9orf72 expansion differ from control participants (HC) and from each other, we used two-sample t-tests to compare smoothed grey matter maps between: (i) C9orf72 + 5 HC1; (ii) C9orf72 À 5 HC1; (iii) C9orf72 + 5 C9orf72 À; (iv) C9orf72 + 4 C9orf72 À. Nuisance covariates included age, sex, scanner, and total intracranial volume.
Although C9orf72 + and C9orf72 À bvFTD showed no significant differences on the FTLD-CDR sum of boxes score (FTLD-CDR-SB), we chose to adjust for the potential influence of clinical severity on neuroimaging results by including FTLD-CDR-SB as a nuisance covariate.
For single-patient voxel-based morphometry, we compared each patient's smoothed grey matter image with a matched control group, following previous approaches (Khan et al., 2012) .
Functional imaging
Preprocessing: We discarded initial functional images to allow for magnetic field stabilization (3 T scanner = 5, 4 T scanner = 6 volumes). Functional images were spatially realigned, unwarped, and slice-time corrected. Unwarping was performed to reduce artefacts due to movement-by-deformation interactions. Co-registration was performed between the mean T 2 * images and the participant's own T 1 -weighted image, and statistical parametric mapping (SPM) non-linear normalization was carried out by calculating the warping parameters between the participant's T 1 -weighted image and the Montreal Neurological Institute T 1 template and applying the parameters to all functional images in the sequence. Subsequently, functional images were resampled at a voxel size of 2 mm 3 . Functional images were smoothed with a 4 mm full-width at half-maximum Gaussian kernel.
Head motion: We used the SPM8 realign algorithm to determine participants' head motion using rigid body parameters. No patient required exclusion for exceeding our threshold of 53 mm translational movement between functional MRI volumes. We computed mean root-mean-square values of volume-to-volume changes in translational (in mm) and rotational (mean Euler angle) movement because these metrics correlate with network connectivity strength (Van Dijk et al., 2012) . Two-sample t-tests revealed a small but statistically significant difference between all patients' and controls' mean root-mean-square values for translational (0.2 AE 0.1 mm versus 0.1 AE 0.1 mm, respectively, P 5 0.01) but not rotational (0.003 AE 0.002 radians versus 0.002 AE 0.001 radians, respectively, P = 0.06) movement. Rather than excluding participants from the small C9orf72 + group, we used the Artifact Detection Tools toolbox (http://www.nitrc.org/projects/ artifact_detect/) to reduce the impact of group differences in motion (Ofen et al., 2007) . Images were identified as outliers if (i) movement from the preceding image exceeded 1 mm (defined by a composite motion score representing the Euclidean sum of three translational and three rotational directions); or (ii) the global mean intensity of the image was greater than three standard deviations from the functional MRI acquisition's mean image. Nuisance covariates in the subject-level regression model included the composite motion score, six motion parameters, and the outlier volumes.
Region of interest analyses: Seed regions of interest were used to derive three ICNs: (i) salience network: right ventral anterior insula (i.e. fronto-insula) (Seeley et al., 2008) ; (ii) SMN: right precentral gyrus (Zielinski et al., 2010) ; and (iii) DMN: right angular gyrus (Seeley et al., 2009) . Seeds consisted of 4 mm radius spheres centred at the chosen coordinates (Supplementary material). Using the MARSBAR toolbox for SPM8 (Brett et al., 2002) , we extracted the average blood oxygen level-dependent signal intensity of all voxels within a given seed for each volume throughout each participant's scan. Resulting region of interest time series served as covariates of interest for whole-brain regression analyses, resulting in three ICN maps for each participant. To reduce effects of physiological noise, we included masks of the CSF, white matter, and non-brain regions as nuisance covariates in the subject-level regression model. Two sample t-tests compared ICN maps for: (i) C9orf72 + versus HC2; (ii) C9orf72 À versus HC2; and (iii) C9orf72 + versus C9orf72 À. We regressed FTLD-CDR-SB as a nuisance covariate for patient group contrasts. Using the Biological Parametric Mapping toolbox (Casanova et al., 2007) , we entered each participant's voxel-based morphometry grey matter map as a set of voxelwise covariates to assess potential effects of atrophy on ICN strength. To evaluate the impact of 'high motion' participants on our major findings, we repeated group ICN analyses after excluding the two C9orf72 + and two C9orf72 À patients with the highest mean root-mean-square values (Supplementary material).
For single-patient functional MRI analyses, we compared each patient's ICN correlation maps with a matched control group (n = 30) using a statistical approach similar to previous single-patient VBM analyses (Khan et al., 2012) .
We masked all group and single patient statistical maps to the relevant ICN. ICN masks were derived from 15 independent healthy control participants using independent component analysis (Habas et al., 2009 ) and included subcortical regions and the cerebellum, regions often omitted in independent component analysis-based network renderings (Zhou et al., 2012) .
Correlations between network connectivity and clinical severity: We correlated patients' NPI composite scores with their single-subject ICN maps to yield a single map per network showing regions significantly correlated with the NPI composite.
Interaction of C9orf72 status with grey matter/network connectivity correlations with NPI: We performed a voxelwise analysis seeking regions in which C9orf72 + and C9orf72 À showed a differing correlation slope for the relationship between NPI and grey matter atrophy or NPI and ICN connectivity using multiple regression in SPM8.
Correlation between salience network connectivity and thalamic grey matter atrophy: We calculated a salience network mean connectivity score for each C9orf72 + patient by calculating the mean beta value across all voxels within a map of regions showing salience network reduction in C9orf72 + bvFTD versus controls, defined using a less stringent joint cluster and extent threshold (P 5 0.1) to capture a broader landscape of connectivity reductions. We first correlated the salience network mean connectivity score with grey matter intensity across the entire brain and then restricted the analysis to the bilateral thalamus. We repeated this mean salience network connectivity correlation with the entire brain and the bilateral thalamus for C9orf72 À bvFTD. We then conducted a seed-based ICN analysis using the thalamic cluster in which grey matter atrophy correlated with salience network connectivity reductions in C9orf72 + bvFTD.
Statistical thresholding for neuroimaging analyses
Voxel-based morphometry: For patient versus control comparisons, grey matter/network connectivity correlations with NPI, and singlepatient analyses, significant clusters were defined using a t-threshold corresponding to P 5 0.05 family-wise error corrected. For contrasts between patient groups, we set a t-threshold corresponding to P 5 0.001 (uncorrected). For correlations between salience network connectivity and grey matter atrophy, we identified significant clusters at P 5 0.01 uncorrected. Clusters contained a minimum of 50 voxels.
Task-free functional MRI: For group-level and single-patient analyses and correlations between network connectivity and clinical severity, we used joint probability distribution thresholding (Poline et al., 1997) with a joint height and extent threshold of P 5 0.05 corrected at the whole-brain level. Binary ICN masks used for visualizing in-network findings were created by tailoring the statistical threshold to generously constrain the search volume for the ICN contrasts at a tscore 5 2.5 (Habas et al., 2009 ).
Statistical analyses
We compared clinical and neuroimaging variables using t-test, ANOVA, Kruskal-Wallis or Mann-Whitney U, as appropriate. Test statistics were considered significant at P 5 0.05 (two-tailed).
Results
Demographic and clinical features
A stronger family history of dementia (Goldman score) characterized C9orf72 + bvFTD (Table 1) . C9orf72 + and C9orf72 À bvFTD showed no significant differences in demographic, clinical, and neuropsychological variables. Predominant executive dysfunction emerged in both groups compared to controls.
Patients with bvFTD with and without C9orf72 expansions show overlapping but distinct atrophy patterns Consistent with previous studies Irwin et al., 2013; Mahoney et al., 2012; Sha et al., 2012; Whitwell et al., 2012) , C9orf72 + bvFTD showed atrophy in bilateral anterior cingulate, dorsolateral prefrontal, orbitofrontal, anterior and posterior insular, and lateral parietal cortices, and precuneus, striatum, and bilateral thalamus compared to controls (Fig. 1 ). C9orf72 À bvFTD exhibited similar but more extensive bilateral atrophy in frontotemporal, insular, cingulate, and striatal regions, with less extensive thalamic atrophy compared with controls. Comparing the bvFTD groups to each other, C9orf72 + bvFTD showed greater atrophy in bilateral medial pulvinar thalamic nuclei, postcentral gyrus, precuneus, and lateral parietal cortex, whereas C9orf72 À bvFTD showed greater atrophy in bilateral anterior cingulate cortex, medial superior frontal gyri, and anterior insulae and left striatum (Supplementary Fig. 1 ).
Patients with bvFTD with and without C9orf72 expansions feature topographically similar connectivity disruptions in the salience and sensorimotor networks
In the salience network, patient groups demonstrated similar connectivity reductions in bilateral anterior cingulate, medial superior frontal gyri, anterior insulae, and thalami compared to controls ( Fig. 2A) . No salience network connectivity differences emerged in the head-to-head patient group comparison. Means with standard deviations in parentheses reported unless noted otherwise. For tests between three groups, the P-value column indicates the P-value of the overall test statistic (ANOVA/Kruskal-Wallis). Superscript symbols indicate post hoc comparisons in which the healthy control group performance was significantly better than C9orf72 carriers ( + ) or non-carriers ( À) at P 5 0.05. FTLD-CDR = Frontotemporal Lobar Degeneration-Clinical Dementia Rating scale; df = degrees of freedom; NA = not applicable; NC = not collected. *NPI composite represents a sum of the frequency Â severity of the following NPI subscale measures: apathy, disinhibition, eating, euphoria, and aberrant motor behaviour.
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Adjusting the salience network analyses for atrophy had little influence on the patient versus control comparisons (Supplementary  Table 2 ). For the SMN, patient groups showed reduced connectivity in bilateral precentral and postcentral gyri and dorsal mid and posterior insulae compared to controls ( Fig. 2A) . Compared to C9orf72 À bvFTD, C9orf72 + bvFTD had reduced SMN connectivity in bilateral striatum and anterior thalami (Fig. 2B ) that was due to connectivity reduction in C9orf72 + and mild enhancement in C9orf72 À (versus controls). No regions showed greater SMN connectivity in C9orf72 + versus C9orf72 À bvFTD. Atrophy-adjusted SMN findings were congruent with the unadjusted results (Supplementary Table 2) .
Removing two patients with high movement from each group produced similar salience network and SMN findings ( Supplementary Fig. 2 ).
Patients with bvFTD with and without C9orf72 expansions exhibit divergent connectivity disruptions in the default mode network Whereas C9orf72 À bvFTD showed both enhanced (bilateral precuneus and right posterior cingulate cortex) and reduced (bilateral striatum, thalamus, midbrain and pons) DMN connectivity, C9orf72 + bvFTD showed no connectivity differences compared to controls (Fig. 2A) . Head-to-head patient group comparisons showed greater DMN connectivity in bilateral precuneus and right posterior cingulate cortex in C9orf72 À bvFTD (Fig. 2B) , reflecting DMN enhancements in C9orf72 À bvFTD compared to controls (Fig. 2C) . Atrophy-adjusted DMN maps produced topographically similar comparisons between C9orf72 À bvFTD and controls and between bvFTD groups (Supplementary Table 2) .
Removing two patients with high movement from each group produced new DMN decreases (midbrain, pons) and an increase (left angular gyrus) in C9orf72 + bvFTD versus controls ( Supplementary Fig. 2A) ; C9orf72 À bvFTD DMN findings ( Supplementary Fig. 2 ) resembled the original results (Fig. 2) .
Behavioural symptom severity correlates with divergent network connectivity changes in salience and default mode networks To examine the relationship between ICN strength and behavioural symptom severity, we correlated an NPI composite score with salience network and DMN connectivity in 26 patients (13 C9orf72 + , 13 C9orf72 À ) for whom the NPI was available. Patients with more severe behavioural impairment showed lower connectivity between the right frontoinsular cortex seed and the left frontoinsula (Fig. 3, top panel) . Adjusting for atrophy showed similar results with additional clusters emerging in left anterior midcingulate and right medial pulvinar nucleus in which lower connectivity predicted more severe behavioural symptoms, and a left anterior cingulate/medial prefrontal cluster in which greater connectivity predicted more severe behavioural symptoms (Supplementary Table 3 ), in keeping with one previous report (Farb et al., 2013) .
In the DMN, stronger connectivity between the right angular gyrus seed and bilateral angular gyri was associated with more severe behavioural symptoms (Fig. 3, bottom panel) . With atrophy adjustment, bilateral posterior cingulate cortex, precuneus and left superior frontal gyri also showed greater DMN Figure 1 Atrophy patterns in bvFTD with and without C9orf72 expansion. Fourteen C9orf72 expansion carriers with bvFTD (five with comorbid MND) exhibit overlapping yet distinct atrophy patterns compared to 14 non-carriers matched for clinical syndrome. Group difference maps derived using voxel-based morphometry illustrate atrophy in C9orf72 + bvFTD (yellow) and C9orf72 À bvFTD (red) relative to healthy control group 1 (HC1). Groups showed overlapping atrophy (orange) in: bilateral pre-and subgenual anterior cingulate cortex, midcingulate cortex, dorsolateral prefrontal cortex, medial orbitofrontal cortex, anterior and posterior insula, striatum, and dorsomedial nucleus of thalamus. C9orf72 + bvFTD showed atrophy in bilateral medial pulvinar nucleus and parietal cortex (not affected in C9orf72 À bvFTD), whereas C9orf72 À bvFTD showed more extensive atrophy in most typical bvFTD-affected regions. Significant clusters were defined at a t-threshold corrected for family-wise error of P 5 0.05 with a minimum cluster size of 50 voxels. Colour bars represent t-scores, and statistical maps are superimposed on the Montreal Neurological Institute template brain. The left side of the axial and coronal images corresponds to the left (L) side of the brain. C9 + = C9orf72 expansion carriers; C9 À = non-carriers for C9orf72 expansion.
connectivity with worsening symptom severity (Supplementary Table 3 ).
When we compared C9orf72 + and C9orf72 À bvFTD for regions with differing correlations between NPI and grey matter atrophy, no significant clusters emerged at a family-wise errorcorrected P 5 0.05 (for P 5 0.001 uncorrected results, see Supplementary material).
Role of medial pulvinar thalamus in C9orf72-related salience network disruption
BvFTD studies performed before identification of the C9orf72 expansion identified the salience network as the primary network Figure 2 Intrinsic connectivity networks in bvFTD with and without C9orf72 expansion. (A) Group difference task-free functional MRI maps reveal seed-based ICN reductions in C9orf72 + bvFTD (dark blue) and C9orf72 À bvFTD (green) relative to healthy control group 2 (HC2) for the three networks. Overlapping reductions are depicted in light blue. Whereas C9orf72 + and C9orf72 À bvFTD showed similar salience network and SMN connectivity reductions, only C9orf72 À bvFTD showed DMN enhancements relative to HC2 (orange). (B) Head-to-head patient group comparisons showed no differences in the salience network but reduced relative SMN and DMN connectivity in C9orf72 + bvFTD; no relative increases in SMN or DMN connectivity occurred in C9orf72 + bvFTD. (C) Bar graphs illustrate mean intrinsic connectivity z-scores for HC2, C9orf72 + bvFTD, and C9orf72 À bvFTD for the salience network, SMN, and DMN. For the salience network, mean connectivity z-scores were derived within the union map of regions present in the C9orf72 + bvFTD 5 HC2 and C9orf72 À bvFTD 5 HC2 contrasts in A and show similar levels of salience network connectivity reduction in both groups. For the SMN, mean connectivity z-scores were derived within the union map of regions present in the C9orf72 + bvFTD 5 HC2 and C9orf72 À bvFTD 5 HC2 contrasts in A (light grey bars) and mean connectivity z-scores were derived from the C9orf72 + bvFTD 5 C9orf72 À bvFTD contrast in B (dark grey bars). For the DMN, mean connectivity z-scores were derived from the C9orf72À bvFTD 5 HC2 contrast in A (light grey bars) and mean connectivity z-scores were derived from the C9orf72 + bvFTD 5 C9orf72 À bvFTD contrast in B (dark grey bars). Error bars represent 1 SEM. Results in A and B are displayed at a joint cluster and extent probability threshold of P 5 0.05, corrected at the whole-brain level. Statistical maps are superimposed on the Montreal Neurological Institute template brain. The left (L) side of the axial images corresponds to the left side of the brain. C9 + = C9orf72 expansion carriers; C9 À = non-carriers for C9orf72 expansion; HC2 = healthy control group 2; SN = salience network.
C9orf72 altered network connectivity Brain 2014: 137; 3047-3060 | 3053 target (Seeley et al., 2009; Zhou et al., 2010) . In the present study, we found comparable salience network disruption in bvFTD regardless of C9orf72 status. This result might seem surprising, considering that C9orf72 + patients showed less severe atrophy within bvFTD-typical salience network 'epicentres' such as the anterior cingulate cortex and frontoinsula (Zhou et al., 2012) . Seeking to reconcile this apparent discordance, we reasoned that salience network connectivity disruption in C9orf72 + bvFTD could be driven by a region of focal, strategic atrophy in C9orf72 + bvFTD. Because this and previous C9orf72 + bvFTD analyses found thalamic atrophy (Irwin et al., 2013; Mahoney et al., 2012; Sha et al., 2012) , we hypothesized that strategic thalamic degeneration might undermine salience network connectivity given the important role of the thalamus within all corticostriato-thalamic networks (Parent and Hazrati, 1995) .
To identify the specific thalamic subnucleus associated with salience network disruption, we performed a voxelwise analysis relating mean salience network connectivity scores to thalamic grey matter volume in C9orf72 + bvFTD, which showed that left medial pulvinar nucleus atrophy predicted more severe salience network connectivity disruption (Fig. 4A ). Although this finding should be interpreted with caution, it suggests that strategic thalamic degeneration may contribute to salience network disruption. To further pursue this possibility, we used the identified left medial pulvinar thalamus cluster (Fig. 4A) to seed an additional intrinsic connectivity analysis. This approach revealed that C9orf72 + bvFTD showed significantly lower connectivity between left medial pulvinar thalamus and key salience network hubs in the anterior cingulate and insular cortices compared to C9orf72 À bvFTD (Fig. 4B) . A more relaxed statistical threshold (t 4 2.0) revealed a second cluster in the right medial pulvinar (data not shown). Expanding the search volume to include the whole brain, we found that reduced salience network connectivity disruption also correlated with atrophy in parietal cortex and cerebellum but not with atrophy in typical bvFTD foci such as anterior insula or anterior cingulate. For C9orf72 À bvFTD, atrophy within bilateral mediodorsal thalamic nuclei and typical bvFTD foci (right anterior insula, bilateral anterior cingulate) predicted more severe salience network connectivity disruption (data not shown).
Single-patient analyses detect network dysfunction in C9orf72 expansion carriers with early-stage and slowly progressive bvFTD
We performed single-patient ICN analyses in two C9orf72 carriers with prodromal bvFTD (Patients 1 and 2) and two with slowly progressive bvFTD (Patients 3 and 4) to characterize ICN alterations in patients with mild or undetectable atrophy (see Supplementary material for patient vignettes).
Patient 1, a female in her early fifties, had a history of mania and was diagnosed with non-amnestic mild cognitive impairment (FTLD-CDR 0.5). Voxel-based morphometry showed atrophy in the left ventrolateral thalamus (Supplementary Table 4) . Reduced salience network connectivity emerged in bilateral anterior cingulate, medial superior frontal gyri, and cerebellum. She had SMN reductions in bilateral caudate. DMN enhancements in left dorsolateral prefrontal cortex, left anterior thalamus and left cerebellum emerged, with no DMN connectivity reductions (Fig. 5) .
Patient 2 was clinically diagnosed with bvFTD during his fifties (FTLD-CDR 0.5), but he lacked some Neary bvFTD criteria (emotional blunting and loss of insight) and manifested only two of six core features (i.e. disinhibition and executive deficits) for possible bvFTD FTDC criteria. Voxel-based morphometry showed no significant differences compared with controls. Salience network reductions were observed in right medial superior frontal gyrus and Figure 3 Symptom severity correlates with intrinsic connectivity network changes in bvFTD. NPI composite score correlated with salience network (top) and DMN (bottom) connectivity in 26 patients (13 C9orf72 + , 13 C9orf72 À ) with bvFTD (10 with MND, five in each patient group). Top panel, left: For the salience network, weaker connectivity between the right frontoinsula seed and the left frontoinsula (blue) predicted greater behavioural symptom severity. Bottom panel, left: For the DMN, higher connectivity between the right angular gyrus and bilateral parietal regions was associated with worsening symptoms. Results are displayed at a joint cluster and extent probability threshold of P 5 0.05, corrected at the whole-brain level. After identifying significant clusters, we plotted salience network mean connectivity scores (right frontoinsula (FI) seed to significant left frontoinsula cluster, top panel, right) and DMN mean connectivity scores (right angular (R Ang) gyrus seed to significant left angular gyrus cluster, bottom panel, right) versus the NPI composite scores, for visualization purposes only. Plots show mean connectivity z-scores within regions identified in the regression analyses for C9orf72 + bvFTD (circle), C9orf72 + bvFTD-MND (filled circle), C9orf72À bvFTD (triangle), C9orf72 À bvFTD-MND (filled triangle) (right). Colour bars represent t-scores. All statistical maps are superimposed on the Montreal Neurological Institute template brain. The left side of the axial image corresponds to the left side of the brain. L = left; R = right.
anterior cingulate, right dorsolateral prefrontal cortex, bilateral thalamus, dorsal midbrain, pons and right cerebellum. SMN connectivity was reduced in the right cerebellum. DMN connectivity reductions were seen in the left putamen and connectivity enhancements emerged at the border between the left angular and middle occipital gyri (Fig. 5) .
Building on previous work describing a 'bvFTD phenocopy' syndrome (Kipps et al., 2007 (Kipps et al., , 2010 Hornberger et al., 2009 ), we recently reported four patients who met possible or probable bvFTD FTDC research criteria but were deemed 'slowly progressive' due to indolent progression and a normal structural MRI (Khan et al., 2012) . Two of four patients harboured the C9orf72 expansion; these patients (Patients 3 and 4 in the present study) met only possible bvFTD FTDC criteria due to a lack of characteristic atrophy on structural MRI.
Patient 3 was a 48-year-old male with slowly progressive bvFTD (FTLD-CDR 1; 'Patient 1' in Khan et al., 2012) . Voxel-based morphometry showed no significant differences compared with controls. Salience network connectivity reductions in bilateral anterior cingulate, bilateral fronto-insulae, bilateral thalamus, dorsal midbrain, pons and bilateral cerebellum were detected (Fig. 5) . SMN connectivity reduction involved the right putamen. The DMN showed enhancements in bilateral dorsolateral prefrontal cortex, left lateral parietal cortex, right precuneus, and right cerebellum (Fig. 5) .
Patient 4 was a 48-year-old female with slowly progressive bvFTD (FTLD-CDR 1; 'Patient 2' in Khan et al., 2012) . Voxelbased morphometry showed no significant differences compared with controls. No salience network disruptions were identified. The SMN showed enhancements in bilateral supplementary motor area, left striatum, left mediodorsal thalamic nucleus, dorsal midbrain, vermis and bilateral cerebellum. Enhanced DMN connectivity emerged in bilateral parieto-occipital cortex, left thalamus, midbrain tectum, pons, and vermis (Fig. 5) . C9orf72 + bvFTD, lower mean salience network connectivity was associated with more severe left medial pulvinar thalamic atrophy (cluster shown at centre, data from cluster plotted at right). Results are displayed at a cluster threshold of P 5 0.01 uncorrected (t = 2.8) with a minimum cluster size of 50 voxels. Cytoarchitecture of the medial pulvinar nucleus is shown for comparison (left, figure reproduced from Byne et al., 2007 with permission) . (B) Group difference task-free functional MRI maps comparing C9orf72 + and C9orf72 À bvFTD reveal ICN alterations to the left medial pulvinar region found in A. C9orf72 + bvFTD shows connectivity reductions to the left medial pulvinar in key salience network foci, including left ventral anterior insula and right anterior midcingulate cortex. Results are displayed at a joint cluster and extent probability threshold of P 5 0.05, corrected at the whole brain level. Statistical maps are superimposed on the Montreal Neurological Institute template brain. Colour bars represent t-scores. The left side of the axial image corresponds to the left side of the brain. C9 + = C9orf72 expansion carriers with bvFTD; C9 + /MND = C9orf72 expansion carriers with bvFTD-MND; C9 À = noncarrier for C9orf72 expansion with bvFTD; C9 À /MND = non-carrier for C9orf72 expansion with bvFTD-MND; eml = extra medullary lamina; L = left; PM = medial pulvinar; RT = reticular nucleus; SN = salience network; 1(v) = ventral pulvinar nucleus; 2 and 3 = lateral pulvinar nucleus.
In summary, three of four C9orf72 carriers with prodromal or slowly progressive bvFTD exhibited single-subject level salience network connectivity reductions, including medial thalamus in Patients 2 and 3; none had salience network connectivity increases. SMN findings were mixed in these patients, who lacked clinical MND. All four single-patient analyses showed DMN enhancements (Fig. 5 ).
Discussion
Patients with bvFTD are united by a core behavioural symptom profile but represent a heterogeneous spectrum of underlying pathobiology. Collapsing these diverse patients into a single group, previous studies have shown that bvFTD is associated with salience network atrophy (Seeley et al., 2009) accompanied by reduced salience network connectivity and increased DMN connectivity Whitwell et al., 2011; Farb et al., 2013) , both of which correlate with clinical severity Farb et al., 2013) . Our key finding is that we demonstrated how patients with bvFTD due to the C9orf72 expansion show a similar pattern of network dysfunction despite contrasting atrophy patterns compared with sporadic bvFTD Irwin et al., 2013; Sha et al., 2012; Whitwell et al., 2012) . We added the SMN, not previously examined in FTD, due to the close link between bvFTD and MND. Our findings show that C9orf72 + and C9orf72 À bvFTD are accompanied by topographically similar salience network and SMN connectivity reductions, suggesting that ICN measures mirrored the clinical syndrome. Although C9orf72 À bvFTD showed DMN enhancements, replicating previous work Whitwell et al., 2011; Farb et al., 2013) , patients with full-blown C9orf72 + bvFTD showed no such enhancements. Seeking to determine how C9orf72 + and C9orf72 À bvFTD produce comparable salience network disruption despite contrasting atrophy patterns, we found a novel link between focal, strategic atrophy of the medial pulvinar nucleus of the thalamus and overall salience network disruption in C9orf72 + bvFTD. We propose that this strategic thalamic lesion aids in generating full-blown bvFTD in patients who lack severe atrophy in core bvFTD structures. At the singlesubject level, patients with prodromal and slowly progressive C9orf72 + bvFTD showed a consistent pattern of salience network and SMN disruption alongside heightened DMN connectivity, suggesting that eventual C9orf72-associated spread into posterior cortices may quell DMN hyperconnectivity present in earlier stages. Overall, the findings illustrate (i) how contrasting regional atrophy patterns can converge on a unifying syndromic pattern of network dysfunction; and (ii) that task-free functional MRI holds promise for detecting prodromal disease in genetic FTD.
Intrinsic connectivity network disruption reconciles distinct atrophy patterns observed in C9orf72 carriers and non-carriers Sporadic bvFTD features early (Seeley et al., 2008) and consistent damage to the anterior insula, anterior cingulate, and orbitofrontal cortices (Boccardi et al., 2005; Schroeter et al., 2007) , which represent key salience network regions. Although C9orf72 + and C9orf72 À bvFTD showed overlapping atrophy in these regions, C9orf72 + patients have less severe atrophy in these areas and greater involvement of medial pulvinar thalamus and parietal cortex. These findings suggest that either mild degeneration in bvFTD 'epicentres' or degeneration in less typical regions is sufficient to produce the C9orf72 + bvFTD clinical syndrome. Matching C9orf72 + and C9orf72 À groups for clinical severity and syndrome, we hypothesized that task-free functional MRI would detect convergent ICN alterations. As predicted, we found salience network connectivity reductions of a similar magnitude and topography in C9orf72 + and C9orf72 À bvFTD, suggesting that the salience network alterations, rather than atrophy, parallel clinical syndrome. Moreover, greater salience network impairment correlated with more severe behavioural symptoms in both groups, further illustrating the clinical relevance of salience network integrity Farb et al., 2013) .
Although previous studies have identified thalamic atrophy as characteristic of C9orf72 carriers (Irwin et al., 2013; Mahoney et al., 2012; Sha et al., 2012) , little attention has been paid to the precise topography of thalamic involvement, a critical issue considering the diverse and specialized functions and connections contained within neighbouring subnuclei. Although both patient groups showed thalamic atrophy relative to controls, atrophy in the bilateral medial pulvinar nuclei was seen only in C9orf72 + bvFTD compared to controls. Searching across the entire thalamus, we found that medial pulvinar atrophy (left 4 right in this sample) predicted reduced salience network connectivity in C9orf72 + bvFTD only, and that C9orf72 + bvFTD shows significantly more impaired left medial pulvinar connectivity to key salience network epicentres compared with C9orf72 À bvFTD. These findings suggest a key role for medial pulvinar thalamus in mediating salience network disruption in C9orf72 + bvFTD.
In contrast to the lateral and inferior pulvinar, whose projections target striate and extrastriate cortex (Robinson and Petersen, 1992; Yeterian and Pandya, 1995) , the medial pulvinar has prominent reciprocal connections with orbitofrontal, parahippocampal, cingulate, insular and amygdalar regions (Jones and Burton, 1976; Mufson and Mesulam, 1984; Romanski et al., 1997) , major nodes of the human salience network (Seeley et al., 2007) . Primate electrophysiological studies suggest that the lateral and inferior pulvinar primarily respond to simple visual stimuli, whereas the medial pulvinar appears to evaluate the salience of visual stimuli (Robinson, 1993) .
Could medial pulvinar dysfunction contribute to psychosis in C9orf72 + bvFTD? Patients with schizophrenia show reduced right medial pulvinar volume, neuron number (Byne et al., 2007) , and D2/D3 receptor binding (Yasuno et al., 2004; Buchsbaum et al., 2006) , suggesting a potential basis for the higher incidence of psychosis in C9orf72 + bvFTD Simó n-Sá nchez et al., 2012; Snowden et al., 2012) . In the present study, 2 of 14 patients with C9orf72 + bvFTD showed signs of psychosis. Although our patient groups showed a similar frequency of psychotic symptoms, future studies may help to determine whether medial pulvinar degeneration predisposes to psychosis in C9orf72 + bvFTD.
Previous bvFTD intrinsic connectivity studies have focused on the salience and default mode networks, but the close relationship between bvFTD and MND compelled us to investigate the SMN, which overlaps with the corticospinal motor system and shows abnormal connectivity in ALS (Mohammadi et al., 2009; Douaud et al., 2011; Tedeschi et al., 2012) . We found that both patient groups had SMN reductions in bilateral primary motor cortices. Compared to C9orf72 À bvFTD, C9orf72 + patients showed greater SMN disruption, perhaps because C9orf72 + bvFTD poses greater risk for subclinical motor system degeneration than does sporadic bvFTD. Longitudinal studies are needed to determine whether SMN alterations predict future clinical motor system deficits.
The DMN was first identified based on its deactivation in response to diverse cognitive and behavioural tasks, many of which recruit the salience network and other networks (Raichle et al., 2001 ). More recent work has shown that the DMN consists of anatomically and functionally distinct subnetworks. A posterior DMN comprised of the angular gyrus, posterior cingulate cortex, and precuneus appears critical for episodic retrieval functions, whereas an anterior DMN anchored by the medial prefrontal cortex supports meta-cognitive functions impaired in bvFTD, such as theory of mind and self-reflection (Spreng and Grady, 2010; Sestieri et al., 2011; Mars, 2012) . DMN findings to date in bvFTD generally support this functional-anatomical segregation, with most studies showing reduced connectivity within anterior but increased connectivity within posterior DMN nodes Whitwell et al., 2011; Farb et al., 2013) , although one study reported DMN increases only (Borroni et al., 2012) and another failed to demonstrate DMN alterations (Filippi et al., 2013) . Our findings suggest that group analyses may yield heterogeneous results because DMN connectivity may depend on the patient's disease stage and whether bvFTD is due to C9orf72. DMN enhancements may occur early in C9orf72 + bvFTD but attenuate as disease spreads more posteriorly. In contrast, when the posterior DMN remains intact, as in most patients with C9orf72 À bvFTD, DMN connectivity intensifies as clinical status and salience network integrity decline.
et al., 2012; Khan et al., 2012) despite major clinical impairment, suggesting that neural dysfunction, rather than neuronal and synaptic loss, must account for the clinical syndrome. To explore this idea, we performed single-patient analyses in four C9orf72 carriers: one with behavioural-executive mild cognitive impairment, one with behavioural symptoms not meeting bvFTD criteria, and two with slowly progressive bvFTD. The single patient analyses were consistent with the group ICN results, with three of four patients showing salience network reductions; all had DMN enhancements. Two patients, including one with a structurally normal MRI, showed prominent medial pulvinar thalamic disconnection from the salience network, suggesting that for some patients with the C9orf72 expansion, early thalamic dysfunction and disconnection may be the primary or even sole driver of salience network functional breakdown. This possibility evokes a neglected literature on 'thalamic dementia,' historically ascribed to a range of aetiologies. Although many patients in this literature suffered from vascular lesions (Schmahmann, 2003; Carrera and Bogousslavsky, 2006) or prion disease Kornfeld and Seelinger, 1994) , others showed either no clear neuropathology or ubiquitin-only immunoreactive inclusions, at times associated with clinical and pathological MND (Kosaka and Mehraein, 1978; Deymeer et al., 1989; Radanovic et al., 2003) . Based on the present findings, we speculate that C9orf72 accounts for most non-vascular, non-prion thalamic dementia in the literature. Most importantly, our single patient studies suggest that bvFTD-related network dysfunction emerges early, may explain clinical deficits, and can be detected with task-free functional MRI, justifying further studies of this modality for early diagnosis in inherited and sporadic FTD.
Limitations and future studies
A limitation of this study was the relatively small group of C9orf72 carriers, which may have limited power to detect subtle effects and required us to combine participants imaged on two MRI scanners whose platforms have not been formally standardized. To minimize the impact of this approach, we balanced groups for scanner and controlled for scanner in all analyses, but the present findings should be interpreted with caution until replicated in larger numbers on a single MRI scanner. C9orf72 carriers present with heterogeneous syndromes, even within families. Thus, group results may not generalize to all patients, but we found that single-patient ICN analyses had the power to detect distinct patterns of altered connectivity consistent with group-level C9orf72 + bvFTD analyses, even in prodromal and slowly progressive disease. Single patient analyses represent an important step toward understanding rare genetic disorders for which it may take years to assemble a sufficient sample for group analyses. Standardization of single-subject task-free functional MRI analyses will be needed prior to clinical use, but our preliminary results build a foundation for withinsubject longitudinal analyses geared toward understanding the natural history of bvFTD and monitoring disease status in response to treatment.
